Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...
The cyclone affected nearly 2 million people and more than 500,000 families across all 25 districts, disrupting livelihoods, ...
The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback